EMEA-000841-PIP01-10

Key facts

Active substance
Aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extracts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) and Secale cereale (Cultivated Rye) pollen (50/50)
Therapeutic area
Pneumology-allergology
Decision number
P/257/2010
PIP number
EMEA-000841-PIP01-10
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
LETI Pharma GmbH
paediatrics@leti.de
Germany
Phone: +49 2302202860
Fax: +49 23022028620
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating